CanadaCEFAZOLIN FOR INJECTION USP powder for solution, CEFAZOLIN SODIUM 10 g/vial (DIN 02308967) from Sandoz Canada, lot PT6813 is affected and can be recognised by the product name, strength, dosage form and lot number. It was recalled because vials may be underfilled; verify if your product is affected, consult your healthcare provider before discontinuing use, contact the recalling firm with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Retailers, Health Care Establishments
Companies: Sandoz Canada Inc. 4600, rue Armand-Frappier, Saint-Hubert, QC, Canada, J3Z 1G5.
How to identify it
Product Name: CEFAZOLIN FOR INJECTION USP; Market Authorization: DIN 02308967; Dosage Form: Powder For Solution; Strength: CEFAZOLIN SODIUM 10 G / VIAL; Lot number: PT6813
The hazard
Vials may be underfilled in the affected lot.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)